Top View
- WO 2021/026099 A1 11 February 2021 (11.02.2021) W P O PCT
- COMP Agenda of the 3-5 October 2017 Meeting
- WO 2017/031223 Al 23 February 2017 (23.02.2017) P O P C T
- Technology Assessment
- Revisiting Intrathecal Therapy in Infants and Children Sharon Conroy, Martin Garnett, Michael Vloeberghs, Richard Grundy, Ian Craven, David Walker
- COMP Agenda of the 11-13 September 2018 Meeting
- Index 451 451 a 9-AC, See 9-Aminocamptothecin Albumin
- Supergen Reports Results of Phase III Rescue Study with Orathecin(TM) (Rubitecan Capsules) Versus 5-FU in Pancreatic Cancer Patients
- Templated Nanoconjugates Joshua Cutler
- COMP Agenda of the 10-12 November 2015 Meeting
- An Evolving Role in Future Drug Discovery
- XELIRI Or FOLFIRI As Salvage Therapy in Advanced Pancreatic Cancer
- TOP2A Is Overexpressed and Is a Therapeutic Target for Adrenocortical Carcinoma
- Understanding Myelodysplastic Syndromes: a Patient Handbook
- Prostate Cancer Hhoott Sshheeeett Us Too! International March / April 2001
- Anti-Proliferative Combination Therapy Comprising Satraplatin Or JM118
- WO 2014/152330 Al 25 September 2014 (25.09.2014) P O P C T
- Novel Chemoradiosensitizers for Cancer Therapy
- WO 2018/073754 Al 26 April 2018 (26.04.2018) W !P O PCT
- Antitumour Treatment: Mitomycin C: a Clinical Update
- COMP Agenda of the 8-10 December 2015 Meeting
- Cytochrome P450 3A-Mediated Metabolism of the Topoisomerase I Inhibitor 9-Aminocamptothecin: Ιmpact on Cancer Therapy
- How Can We Deal with the Explosion of New Treatments?
- 10 Clinical Studies of Rubitecan (9-Nitro 20(S) Camptothecin)
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines
- University of Pittsburgh School of Pharmacy Annual Report 2006-07
- Camptothecin-Discovery, Clinical Perspectives and Biotechnology
- 142 Discovery of New Anticancer Agents from Higher Plants Li Pan1
- (COMP) Draft Agenda for the Meeting on 05-07 September 2017
- 1455.Full-Text.Pdf
- Beyond First-Line Chemotherapy for Advanced Pancreatic Cancer: an Expanding Array of Therapeutic Options?
- Role of Plants in Anticancer Drug Discovery
- A Pharmacokinetic and Pharmacodynamic Study on Metronomic Irinotecan in Metastatic Colorectal Cancer Patients
- Topoisomerase I Inhibitors: Camptothecins and Beyond
- Draft COMP Agenda 6-8 December 2016
- Novel Camptothecin Derivatives
- WO 2016/025904 Al 18 February 2016 (18.02.2016) P O P C T
- Origins, Genetic Landscape, and Emerging Therapies of Small Cell Lung Cancer
- Draft Agenda for the COMP Meeting on 16-18 February 2016
- Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016